Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia. (Leukemia, 2013)

(untitled) - Craddock, C; Quek, L; Goardon, N; Freeman, S; Siddique, S; Raghavan, M; Aztberger, A; Schuh, A; Grimwade, D; Ivey, A; Virgo, P; Hills, R; et al.